About This Fund
The Limerston Capital Partners II fund has a total commitment of £245 million and is focused on the UK with potential expansions to the US and Continental Europe. The investor base is diverse, including commitments from the US, Asia, and Europe, and includes corporate pension plans, university endowments, charitable foundations, family offices, and fund managers.
The fund's strategy targets businesses with EBITDA of between £5 million and £15 million in sectors such as Healthcare, Lifesciences, Business Services, and Testing, Inspection, Certification & Compliance (TICC). The fund aims to provide opportunities for buy-and-build led by ambitious management teams to accelerate growth.
The Fund has already completed three investments: Scottish holiday parks company Largo Leisure, drug discovery, development and manufacturing organisation Concept Life Sciences, and stability storage business Astoriom.
WHR Capital acted as the placement agent and Ropes & Gray LLP served as legal adviser for the Fund.